7 completed, 2 unknown. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 7, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow Vaccine: new trials by email Literature Review of Vaccine trials Research Report on Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster the tested vaccine, the control vaccine - Vaccine | Phase 3 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 1200 | 2022-07-19 | 2026-06-29 |
| Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive" Vaccine for intramuscular injection, Placebo comparator (without active ingredient) for intramuscular injection - Vaccine | Phase 3 | Unknown | Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 300 | 2022-04-01 | 2023-03-07 |
| An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac) CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS", The data from volunteers from the control group - Coronavirus Infections, Vaccine | Phase 3 | Unknown | Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products | 29000 | 2021-07-07 | 2023-02-08 |
| Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian Vi-DT Typhoid Conjugate Vaccine - Vaccine | Phase 2 / Phase 3 | Completed | PT Bio Farma | 188 | 2021-05-03 | 2025-06-03 |
| Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese experimental vaccine, Positive control vaccine 1, Positive control vaccine 2 - Vaccine | Phase 3 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 1950 | 2016-05-12 | 2018-10-22 |
| A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older ASP7374 - Influenza, Vaccine | Phase 3 | Completed | UMN Pharma Inc. | 55 | 2015-02-01 | 2017-09-29 |
| Study of ASP7374, Cell-culture-derived Influenza Vaccine ASP7374, approved egg-derived TIV - Influenza, Vaccine | Phase 3 | Completed | UMN Pharma Inc. | 900 | 2013-10-01 | 2017-09-29 |
| A Study to Evaluate Intramuscular ASP7374 ASP7374 - Influenza, Vaccine | Phase 3 | Completed | UMN Pharma Inc. | 55 | 2013-10-01 | 2017-09-29 |
| Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008 trivalent split influenza vaccine - Seasonal Influenza, Vaccine | Phase 3 | Completed | Novartis | 120 | 2007-06-01 | 2008-04-22 |
Influenza, Human (4) · COVID-19 (2) · Coronavirus Infections (2)
Infections (6) · RNA Virus Infections (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Virus Diseases (6) · Orthomyxoviridae Infections (4) · Coronaviridae Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2)
Injections, Intramuscular (1) · Vaccines (1)
UMN Pharma Inc. (3) · Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products (2) · Jiangsu Province Centers for Disease Control and Prevention (2) · Novartis (1) · PT Bio Farma (1)
Japan (3) · Russia (2) · China (1) · Germany (1) · Indonesia (1)